Document is current

Article History

First Online: 23 September 2020

Declarations

:

: This study was sponsored by Pfizer Japan Inc.

: Nozomi Ebata-Kogure, Kazutaka Nozawa, and Koichi Fujii are employees of Pfizer Japan Inc. and hold stock/stock options of Pfizer Inc., and Aya Murakami is an employee of Clinical Study Support, Inc. and was involved in the study based on the contract with Pfizer Japan Inc. Yingsong Lin, Takahiro Ushida, and Shogo Kikuchi were not financially compensated for their collaboration in this project or the development of this manuscript; however, Takahiro Ushida has received honorariums from Pfizer Japan Inc. outside of this work. The authors report no other conflicts of interest in this work.

: The datasets that support the findings of this study are available from the commercial database provider Medical Data Vision Co., Ltd. (MDV; Tokyo, Japan). The dataset analyzed in this study cannot be shared publicly due to contractual agreements between MDV and medical facilities. For inquiries regarding access to the dataset used in this study, please contact MDV (https://www.mdv.co.jp/).

: Not applicable.

: Nozomi Ebata-Kogure contributed to the conception and planning of the work, drafting and revision of the manuscript. Aya Murakami performed data analysis and revised the manuscript. Kazutaka Nozawa, Kocihi Fujii, Yingsong Lin, Takahiro Ushida and Shogo Kikuchi contributed to the critical interpretation and revision of the manuscript. All authors approved the final manuscript and agreed to be accountable for all aspects of work ensuring integrity and accuracy.

: Not applicable.